More Post from the Author
- TestMu AI (anteriormente LambdaTest) presenta los ganadores del 2025 Partner of the Year Award
- L'AGENCE PRESENTS ITS FALL 2026 COLLECTION & PARTNERS WITH GOOGLE ON EXPERIENTIAL AI VIRTUAL TRY-ON ACTIVATION
- ACT Capital Advisors Represents Key Trucking in its Sale to Estes Logistics
- Rezolve Ai acquiert Reward pour 230 millions de dollars afin d'acclrer l'innovation dans les secteurs de la banque et du commerce propulss par l'IA
- /C O R R E C T I O N -- PayJoy/
Indivior Statement RE: Delayed FDA Approval of SUBLOCADE Label Changes
Published on Wed 12 Feb 2025 8:07:04 UTC
RICHMOND, Va., Feb. 12, 2025 /PRNewswire/ --Indivior PLC (Nasdaq/LSE: INDV)provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025:
Yesterday, February 11th, the FDA informed Indivior that, following acceptance of the proposed label for SUBLOCADE, there were no outstanding items to address, but that final review of the SUBLOCADE label changes has been delayed.
Indivior will provide further updates on the status of the approval of the proposed SUBLOCADE label changes as appropriate.
SOURCE Indivior PLC
More Post from the Author
- TestMu AI (anteriormente LambdaTest) presenta los ganadores del 2025 Partner of the Year Award
- L'AGENCE PRESENTS ITS FALL 2026 COLLECTION & PARTNERS WITH GOOGLE ON EXPERIENTIAL AI VIRTUAL TRY-ON ACTIVATION
- ACT Capital Advisors Represents Key Trucking in its Sale to Estes Logistics
- Rezolve Ai acquiert Reward pour 230 millions de dollars afin d'acclrer l'innovation dans les secteurs de la banque et du commerce propulss par l'IA
- /C O R R E C T I O N -- PayJoy/